Brand

Camber Pharmaceuticals Inc Recalls

5 recalls on record. Search official CPSC, FDA, and USDA datasets for every recall issued for Camber Pharmaceuticals Inc.

5Total Recalls
1Critical
1.1MUnits Affected
Mar 13, 2023Most Recent
All Recalls

Every Camber Pharmaceuticals Inc Recall

Sorted by most recent. Click any recall for full details.

5 recalls
CriticalFDA
Camber Pharmaceuticals Inc.
Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08...
Oral Drugs·1,568 affected·Mar 13, 2023
RecallFDA
Camber Pharmaceuticals, Inc
Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscatawa...
Oral Drugs·0 affected·Dec 6, 2022
High RiskFDA
Camber Pharmaceuticals Inc
Losartan Potassium Tablets USP, 50 mg, Rx only, a) 30 count (NDC 31722-701-30), b) 90 count (NDC 31722-701-90), c) 1000 count (NDC 31722-...
Oral Drugs·69,712 affected·Feb 28, 2019
High RiskFDA
Camber Pharmaceuticals Inc
Losartan Potassium Tablets USP, 100 mg, Rx only, a) 30 count (NDC 31722-702-30), b) 90 count (NDC 31722-702-30), c) 1000 count (NDC 31722...
Oral Drugs·683,641 affected·Feb 28, 2019
High RiskFDA
Camber Pharmaceuticals Inc
Losartan Potassium Tablets USP, 25 mg, Rx only, a) 90 count (NDC 31722-700-90), b) 500 count (NDC 31722-700-05) and c) 1000 count (NDC 31...
Oral Drugs·351,732 affected·Feb 28, 2019